Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 16 medicines
Health Canada · 7 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
PHARMAC · 6 medicines
Show all 6FDA · 4 medicines
SFDA · 3 medicines · Historical list
HALMED · 2 medicines
AEMPS · 1 medicine
AIFA · 1 medicine
CBG-MEB · 1 medicine
MS · 1 medicine · Historical list
ALIMS · 1 medicine
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
46 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ifosfamide | United States | 1GM/20ML, 1GM/VIAL, 3GM/60ML … | injectable | Marketed | Fresenius Kabi USA |
| Ifosfamide/Mesna KitCombination | United States | 1GM/20ML; 1GM/10ML (50MG/ML, 3GM/60ML; 1GM/10ML (50MG/ML | injectable | Not marketed | Teva Pharms USA |
| Ifosfamide for Injection | Canada | 1 G / VIAL | Powder For Solution | Cancelled | Fresenius Kabi Canada LTD |
| Ifosfamide for Injection | Canada | 3 G / VIAL | Powder For Solution | Cancelled | Fresenius Kabi Canada LTD |
| Ifex | United States | 1GM/VIAL, 3GM/VIAL | injectable | Marketed | Baxter Hlthcare |
| Ifosfamida | Brazil | Authorised | Eurofarma Laboratorios S.A. | ||
| Ifex/Mesnex KitCombination | United States | 1GM/VIAL; 100MG/ML, 3GM/VIAL; 100MG/ML | injectable | Not marketed | Baxter Hlthcare |
| Ifex | Canada | 1 G / VIAL | Powder For Solution | Marketed | Baxter Corporation |
| Ifex | Canada | 3 G / VIAL | Powder For Solution | Marketed | Baxter Corporation |
| Ifosfamida | Brazil | Cancelled | Glenmark Farmacêutica Ltda | ||
| Ifosfamida | Brazil | Cancelled | Prodotti Laboratório Farmacêutico Ltda. | ||
| Ifomid-MCombination | New Zealand | Inj 2 g vial with mesna 3 x 100 mg per ml, 4 ml ampoule | Funded | ||
| Ifomid - MCombination | New Zealand | Inj 2 g vial with mesna 3 x 100 mg per ml, 4 ml ampoule | Funded | ||
| Tronoxal 1.000 MG Polvo Para Solución Para Perfusión | Spain | 1 g | polvo para solución para perfusión | Marketed | Baxter S.L. |
| Lifos | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| Holoxan, poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | Baxter B.V. | |
| Holoxan | Italy | Polvere per soluzione iniettabile | Authorised | Baxter S.P.A. | |
| Holoxan 1000 mg prašak za otopinu za injekciju/infuziju | Croatia | Prašak za otopinu za injekciju / infuziju | Marketed | Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija | |
| HOLOXAN FOR INJECTION 1 g/25 ml | Singapore | 1 g/25 ml | injection, powder, for solution | Authorised | Baxter Healthcare (Asia) Pte LTD |
| Evolox | Brazil | Authorised | Farmarin Industria e Comercio Ltda | ||
| Holoxan® | Serbia | 1g | prašak za rastvor za injekciju/infuziju | Authorised | Diacell D.O.O. Beograd |
| Holoxane | Brazil | Authorised | Baxter Hospitalar Ltda | ||
| Holoxan 500 mg prašak za otopinu za injekciju/infuziju | Croatia | Prašak za otopinu za injekciju / infuziju | Not marketed | Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija | |
| Holoxan | New Zealand | Inj 1 g | Funded | ||
| Holoxan | New Zealand | Inj 2 g | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
